Literature DB >> 15294974

pH-triggered microparticles for peptide vaccination.

W Nicholas Haining1, Daniel G Anderson, Steven R Little, Michael S von Bergwelt-Baildon, Angelo A Cardoso, Pedro Alves, Kostas Kosmatopoulos, Lee M Nadler, Robert Langer, Daniel S Kohane, Michael S von Berwelt-Baildon.   

Abstract

Improving vaccine delivery to human APCs is a way to increase the CTL response to vaccines. We report the use of a novel pH-triggered microparticle that exploits the ability of APCs to cross-present MHC I-restricted Ags that have been engulfed in the low pH environment of the phagosome. A model MHC class I-restricted peptide Ag from the influenza A matrix protein was encapsulated in spray-dried microparticles composed of dipalmitoylphosphatidylcholine and the pH-sensitive polymethacrylate Eudragit E100. Release of the peptide from the particle was triggered by a drop in pH to the acidity normally found in the phagosome. The particles were efficiently phagocytosed by human monocytes and dendritic cells with minimal cellular toxicity and no functional impairment. Encapsulation of the peptide in the microparticles resulted in efficient presentation of the peptide to CD8(+) T cells by human dendritic cells in vitro, and was superior to unencapsulated peptide or peptide encapsulated in an analogous pH-insensitive particle. Vaccination of human HLA-A*0201 transgenic mice with peptide encapsulated in pH-triggering microparticles resulted in priming of CTL responses. These microparticles can be modified to coencapsulate a range of adjuvants along with the Ag of interest. Encapsulation of MHC I epitopes in pH-triggered microparticles increases Ag presentation and may improve CD8(+) T cell priming to peptide vaccines against viruses and cancer.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15294974     DOI: 10.4049/jimmunol.173.4.2578

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

1.  Virus aggregating peptide enhances the cell-mediated response to influenza virus vaccine.

Authors:  Jeremy C Jones; Erik W Settles; Curtis R Brandt; Stacey Schultz-Cherry
Journal:  Vaccine       Date:  2011-08-10       Impact factor: 3.641

2.  Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles.

Authors:  Hong Shen; Anne L Ackerman; Virginia Cody; Alessandra Giodini; Ella R Hinson; Peter Cresswell; Richard L Edelson; W Mark Saltzman; Douglas J Hanlon
Journal:  Immunology       Date:  2006-01       Impact factor: 7.397

Review 3.  Pharmaceutical particle engineering via spray drying.

Authors:  Reinhard Vehring
Journal:  Pharm Res       Date:  2007-11-28       Impact factor: 4.200

Review 4.  Polymers in the prevention of peritoneal adhesions.

Authors:  Yoon Yeo; Daniel S Kohane
Journal:  Eur J Pharm Biopharm       Date:  2007-07-20       Impact factor: 5.571

5.  Intracellular delivery of a protein antigen with an endosomal-releasing polymer enhances CD8 T-cell production and prophylactic vaccine efficacy.

Authors:  Suzanne Foster; Craig L Duvall; Emily F Crownover; Allan S Hoffman; Patrick S Stayton
Journal:  Bioconjug Chem       Date:  2010-11-02       Impact factor: 4.774

6.  Tunable degradation of acetalated dextran microparticles enables controlled vaccine adjuvant and antigen delivery to modulate adaptive immune responses.

Authors:  Naihan Chen; Monica M Johnson; Michael A Collier; Matthew D Gallovic; Eric M Bachelder; Kristy M Ainslie
Journal:  J Control Release       Date:  2018-02-02       Impact factor: 9.776

Review 7.  Hitting Undruggable Targets: Viewing Stabilized Peptide Development through the Lens of Quantitative Systems Pharmacology.

Authors:  Lydia Atangcho; Tejas Navaratna; Greg M Thurber
Journal:  Trends Biochem Sci       Date:  2018-12-15       Impact factor: 13.807

8.  Drug delivery and translation.

Authors:  Daniel S Kohane; Robert Langer
Journal:  Drug Deliv Transl Res       Date:  2011-02       Impact factor: 4.617

Review 9.  Emerging nanotechnologies for cancer immunotherapy.

Authors:  Sourabh Shukla; Nicole F Steinmetz
Journal:  Exp Biol Med (Maywood)       Date:  2016-05-04

10.  Spray-dried chitosan microparticles for cellular delivery of an antigenic protein: physico-chemical properties and cellular uptake by dendritic cells and macrophages.

Authors:  Chirasak Kusonwiriyawong; Vimolmas Lipipun; Nontima Vardhanabhuti; Qiang Zhang; Garnpimol C Ritthidej
Journal:  Pharm Res       Date:  2013-03-13       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.